Abstract:Yumei Ge, 1, &ast Xiaoyu Gou, 1, &ast Xiaoyan Dong, 1, 2 Yumeng Peng, 1, 3 Fangfang Yang 4 1 Department of Laboratory Medicine Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, People's Republic of China; 2 The Second Medical College, Zhejiang Chinese Medical University, Hangzhou, 310014, People's Republic of China; 3 Department of Clinical Laboratory Diagnostics, Bengbu Medical College, Bengbu, 233030, People's Republic of China; 4 Department of Clinical Laboratory, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, 621000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fangfang Yang, Department of Clinical Laboratory, The Third Hospital of Mianyang (Sichuan mental health center), Mianyang, Sichuan, 621000, People's Republic of China, Email Purpose: At present, there is no gold standard or unified standard for the diagnosis of neurosyphilis, and the rate of misdiagnosis is high. The diagnosis of neurosyphilis is still challenging. This study compared the clinical indicators between neurosyphilis and latent syphilis infection in the central nervous system. The purpose of this study was to provide evidence for the differential diagnosis and prognosis of patients with neurosyphilis and latent syphilis infection of the central nervous system. Methods: The clinical data of 59 patients with neurosyphilis and 30 patients with latent syphilis infection in the nervous system from 2008 to 2021 were analyzed. The cerebrospinal fluid and serum biochemical markers were evaluated for all patients. Results: CSF-nucleated cells, CSF-TRUST, CSF-totalprotein and CSF-IgG ( P 450 mg/L) or nucleated cells (> 5 cells/L) indicates the destruction of the blood-brain barrier and intracranial inflammatory reaction, which is helpful to the diagnosis of neurosyphilis. It plays an important role in the judgment of curative effect and prognosis of the disease as well. 5 Guidelines from different regions of the world indicate that the positive cerebrospinal fluid VDRL/RPR /TRUST can be used as the marker for the diagnosis of neurosyphilis. 6,7 Patients with cerebrospinal fluid VDRL positive and accompanied by neurological symptoms and signs, excluding blood contamination of cerebrospinal fluid, can be diagnosed with neurosyphilis. If the patient's serological test is positive, cerebrospinal fluid VDRL is negative, but the patient's cerebrospinal fluid cell count or protein determination is abnormal, and accompanied by neurosyphilis symptoms and signs, the diagnosis of neurosyphilis should be considered. Studies have shown that CSF-TRUST has the same diagnostic ability as CSF-VRDL, -Abstract Truncated-

High HbA1c Level is Correlated with Blood-Brain Barrier Disruption in Syphilis Patients.

Preliminary Study on the Effect of Impaired Glucose Tolerance on Blood-Brain Barrier Permeability in Non-Neurosyphilis Patients

Clinical Characteristics, Diagnosis, and Predictors of Neurosyphilis Patients with Human Immunodeficiency Virus Co-Infection

Association Between Neurosyphilis and Diabetes Mellitus: Resurgence of an Old Problem.

Assessing Cerebrospinal Fluid Abnormalities in Neurosyphilis Patients Without Human Immunodeficiency Virus Infection

Metabolic Disorders in Patients with Central Nervous System Infections: Associations with Neurosyphilis.

Increased CCL24 and CXCL7 Levels in the Cerebrospinal Fluid of Patients with Neurosyphilis

Altered Brain Function in Young HIV Patients with Syphilis Infection: A Voxel-Wise Degree Centrality Analysis.

Blood Brain Barrier Disruption in Diabetic Stroke Related to Unfavorable Outcome

Epigenetic Changes in Cerebrospinal Fluid and Blood of People with Neurosyphilis

Comparing Noninvasive Predictors of Neurosyphilis among Syphilis Patients with and Without HIV Co-Infection Based on the Real-World Diagnostic Criteria: A Single-Center, Retrospective Cohort Study in China.

Exosomal Microrna Profiles from Serum and Cerebrospinal Fluid in Neurosyphilis.

Cerebrospinal Fluid Changes and Clinical Features of Neurosyphilis Compared with Latent Syphilis Infection in the Central Nervous System: A Cross-Sectional Study

Characteristics of Brain White Matter Microstructure in HIV Male Patients With Primary Syphilis Co-Infection

Aberrant Humoral Immune Responses in Neurosyphilis: Cxcl13/Cxcr5 Play A Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid

The associations of increased cerebral small vessel disease with cognitive impairment in neurosyphilis presenting with ischemic stroke

Potential mechanisms of Treponema pallidum breaching the blood-brain barrier

Analysis of Treponema Pallidum DNA and CXCL13 in Cerebrospinal Fluid in HIV-Negative Syphilis Patients

CCS01.1 Neurosyphilis is More Common among Malignant Syphilis: Based on Case Series Evidence

LB1.70 Aberrant humoral immune responses in neurosyphilis: cxcl13/cxcr5 play a pivotal role for b cell recruitment to the csf

The clinical and laboratory features of neurosyphilis in HIV-infected patients: A retrospective study in 92 patients.